| PCV7 | PHiD-CV10 | Absolute Risk Difference [95 % CI] | P value | ||
---|---|---|---|---|---|---|
 | N, Mean (SD) | % | N, Mean (SD) | % |  |  |
ED swabs | 85 | Â | 59 | Â | Â | Â |
Children with ED | 60a | Â | 47 | Â | Â | Â |
Mean age (mo) | 20 (7.6) | Â | 18 (6.9) | Â | Â | Â |
Bilateral ED swabs | 19 | Â | 13 | Â | Â | Â |
 CSOM | 11 |  | 8 |  |  |  |
 AOMwiP | 6 |  | 3 |  |  |  |
 AOMwiP and CSOM | 2 |  | 2 |  |  |  |
All ED swabs | 85 | Â | 59 | Â | Â | Â |
  > =3-dose schedule | 77/85 | 91 % | 53/59 | 90 % |  |  |
 One dose PCV13 | 0 |  | 9/59 | 15 % |  |  |
 NTHi | 39/73m- | 53 % | 19/55 | 35 % | −19 % | 0.03 |
[−36 to −2] | ||||||
 Spn | 20/83 | 24 % | 8/56 | 14 % | −10 % | 0.16 |
[−23 to 3] | ||||||
 NTHi and Spn | 12/69 | 17 % | 5/55 | 9 % | −8 % | 0.18 |
[−20 to 3] | ||||||
 Mcat | 1/61 | 2 % | 4/55 | 7 % | 6 % | 0.14 |
[−2 to 13] | ||||||
 Sa | 44/82 | 54 % | 24/56 | 43 % | −11 % | 0.21 |
[−28 to 6] | ||||||
 Spn serotypesb | 10A(n = 4) 7Fc(n = 2) 11Cd(n = 2) 10F 12F 16Fd 17Fc 19Ad 19Fd 23Fc 6A 6C | 11Ad(n = 2) 15Ac 16Fd 19Fd 21 22A 35F |  |  | ||
Children with ED (Bilateral data combined) | 60 | Â | 47 | Â | Â | Â |
  > =3 dose schedule | 54/60 | 90 % | 42/47 | 89 % |  |  |
 One dose PCV13 | 0 |  | 9/47 | 19 % |  |  |
 NTHi | 33/54m- | 61 % | 15/44 | 34 % | −27 % | 0.008 |
[−46 to −8] | ||||||
 Spn | 15/60 | 25 % | 8/45 | 18 % | −7 % | 0.38 |
[−23 to 8] | ||||||
 NTHi and Spn | 11/60 | 18 % | 5/45 | 11 % | −7 % | 0.31 |
[−21 to 6] | ||||||
 Mcat | 1/46 | 2 % | 3/44 | 7 % | 5 % | 0.27 |
[−4 to 13] | ||||||
 Sa | 35/59 | 59 % | 22/45 | 49 % | −10 % | 0.29 |
[−30 to 9] |